Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dry age-related macular degeneration
|
1 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Exudative age-related macular degeneration
|
109 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.800 | 0.950 | 20 | 2005 | 2018 | ||||
exudative macular degeneration
|
69 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||
Familial (FPAH)
|
276 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Geographic Atrophy
|
81 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.760 | 1.000 | 7 | 2006 | 2018 | ||||
Glomerulonephritis, Membranoproliferative
|
3 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Glycogen storage disease type II
|
269 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.100 | 0.889 | 27 | 2006 | 2019 | ||||
Hypercholesterolemia, Familial
|
1423 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Hypertensive disease
|
1085 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.020 | 0.500 | 2 | 2008 | 2012 | ||||
Impaired cognition
|
348 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Ischemic stroke
|
704 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1 | 2006 | 2006 | |||||
Kidney Failure, Chronic
|
425 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Lobular Neoplasia
|
3 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Low Vision
|
51 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Lupus Erythematosus, Systemic
|
1172 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Lupus Nephritis
|
64 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Macular degeneration
|
16 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.020 | 0.500 | 2 | 2008 | 2019 | ||||
MACULAR DEGENERATION, AGE-RELATED, 4 (disorder)
|
5 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.700 | 0 | |||||||
Major Depressive Disorder
|
1451 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Malignant neoplasm of lung
|
1142 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Membranoproliferative Glomerulonephritis, Type II
|
3 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Multifocal choroiditis
|
1 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Multiple Sclerosis
|
1022 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||
Myocardial Infarction
|
680 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.030 | 0.333 | 3 | 2006 | 2007 | ||||
Nevus elasticus
|
5 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2008 | 2008 |